Mateen Dalal currently works for healthcareopportunity.org as a content developer, writing valuable pieces pertaining to the healthcare industry. Having completed his graduation in electronics and telecommunication engineering, Mateen also boasts of a short-term experience in test engineering. When he isn’t penning down insightful pieces, Mateen spends time trekking across town and enjoying at the gaming zone. He can be contacted at- [email protected] | https://twitter.com/MateenDalal
Lupin Limited has reportedly received the European Commission’s approval for its specialty drug NaMuscla used in the treatment of a rare neuromuscular disorder. As per trusted sources, Lupin is …
QIAGEN N.V., has recently announced that it has entered into a definitive agreement with N-of-One, Inc., the privately-held American molecular decision support company, which is renowned for innovating clinical …
L’Oréal is committed to investing in technology and the latest wearable tech can be used by dermatologists to access patients’ skin conditions and create skin health plans. L’Oréal, the …
A new breathalyzer test that is most likely to revolutionize the diagnosis of cancer will reportedly undergo clinical trials in Britain. As per credible sources, the breath test involves …
The investment will be used to develop and support the existing company portfolio in the coming years. Leading biotech-focused venture capital firm, Atlas Venture has recently raised around $250 …
The investment will be used to fund the development of Antengene’s lead ATG-010 (selinexor), ATG-008 programs and clinical-stage assets. Renowned clinical-stage biopharmaceutical company, Antengene Corp. has recently completed a $120 …
Clinical-stage biotechnology company APRINOIA, which is known for therapeutic and diagnostic imaging tools for neurodegenerative diseases, has reportedly signed a non-exclusive licensing agreement with Celgene Corporation. As per trusted …
Gala Pharmaceutical California Inc., which is a subsidiary of Gala Pharmaceutical, Inc., has recently announced that it has been granted a Temporary License by the State of California for …
Dr. Reddy’s Laboratories Ltd., an Indian multinational pharmaceutical company in Hyderabad, has reportedly declared the launch of the oral suspension drug Sevelamer Carbonate in the U.S. market. Sources claim …
BrainStorm Cell Therapeutics, a biotechnology company that is engaged in the development of autologous stem cell therapies, recently announced that it would be expanding its autologous cell manufacturing capacity …
